These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 29115601)

  • 21. Targeted delivery of 20(S)-ginsenoside Rg3-based polypeptide nanoparticles to treat colon cancer.
    Qiu R; Qian F; Wang X; Li H; Wang L
    Biomed Microdevices; 2019 Feb; 21(1):18. PubMed ID: 30783757
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The sirtuin inhibitor tenovin-6 upregulates death receptor 5 and enhances cytotoxic effects of 5-fluorouracil and oxaliplatin in colon cancer cells.
    Ueno T; Endo S; Saito R; Hirose M; Hirai S; Suzuki H; Yamato K; Hyodo I
    Oncol Res; 2013; 21(3):155-64. PubMed ID: 24512730
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bioactive Peptides Sensitize Cells to Anticancer Effects of Oxaliplatin in Human Colorectal Cancer Xenografts in Nude Mice.
    Li X; Xia L; Ouyang X; Suyila Q; Su L; Su X
    Protein Pept Lett; 2019; 26(7):512-522. PubMed ID: 30950338
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibitory effect of ginsenoside Rg3 on ovarian cancer metastasis.
    Xu TM; Cui MH; Xin Y; Gu LP; Jiang X; Su MM; Wang DD; Wang WJ
    Chin Med J (Engl); 2008 Aug; 121(15):1394-7. PubMed ID: 18959116
    [TBL] [Abstract][Full Text] [Related]  

  • 25. UCN-01 enhances cytotoxicity of irinotecan in colorectal cancer stem-like cells by impairing DNA damage response.
    Signore M; Buccarelli M; Pilozzi E; De Luca G; Cappellari M; Fanciulli M; Goeman F; Melucci E; Biffoni M; Ricci-Vitiani L
    Oncotarget; 2016 Jul; 7(28):44113-44128. PubMed ID: 27286453
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ursolic acid inhibits colorectal cancer angiogenesis through suppression of multiple signaling pathways.
    Lin J; Chen Y; Wei L; Hong Z; Sferra TJ; Peng J
    Int J Oncol; 2013 Nov; 43(5):1666-74. PubMed ID: 24042330
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ginsenoside Rg3 inhibits angiogenesis in a rat model of endometriosis through the VEGFR-2-mediated PI3K/Akt/mTOR signaling pathway.
    Cao Y; Ye Q; Zhuang M; Xie S; Zhong R; Cui J; Zhou J; Zhu Y; Zhang T; Cao L
    PLoS One; 2017; 12(11):e0186520. PubMed ID: 29140979
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Remodeling the homeostasis of pro- and anti-angiogenic factors by Shenmai injection to normalize tumor vasculature for enhanced cancer chemotherapy.
    Cheng L; Liu W; Zhong C; Ni P; Ni S; Wang Q; Zhang Q; Zhang J; Liu J; Xu M; Yao X; Cen X; Wang G; Jiang C; Zhou F
    J Ethnopharmacol; 2021 Apr; 270():113770. PubMed ID: 33388426
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ginsenoside Rg3 Inhibition of Thyroid Cancer Metastasis Is Associated with Alternation of Actin Skeleton.
    Wu W; Zhou Q; Zhao W; Gong Y; Su A; Liu F; Liu Y; Li Z; Zhu J
    J Med Food; 2018 Sep; 21(9):849-857. PubMed ID: 30136914
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synergistic antitumor activity of sorafenib in combination with epidermal growth factor receptor inhibitors in colorectal and lung cancer cells.
    Martinelli E; Troiani T; Morgillo F; Rodolico G; Vitagliano D; Morelli MP; Tuccillo C; Vecchione L; Capasso A; Orditura M; De Vita F; Eckhardt SG; Santoro M; Berrino L; Ciardiello F
    Clin Cancer Res; 2010 Oct; 16(20):4990-5001. PubMed ID: 20810384
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ursolic acid synergistically enhances the therapeutic effects of oxaliplatin in colorectal cancer.
    Shan J; Xuan Y; Zhang Q; Zhu C; Liu Z; Zhang S
    Protein Cell; 2016 Aug; 7(8):571-85. PubMed ID: 27472952
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhanced oral bioavailability and anti-tumour effect of paclitaxel by 20(s)-ginsenoside Rg3 in vivo.
    Yang LQ; Wang B; Gan H; Fu ST; Zhu XX; Wu ZN; Zhan DW; Gu RL; Dou GF; Meng ZY
    Biopharm Drug Dispos; 2012 Nov; 33(8):425-36. PubMed ID: 22898996
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Inhibitory Effect of Ginsenoside Rg3 Combined With 5-Fluorouracil on Tumor Angiogenesis and Tumor Growth of Colon Cancer in Mice: An Experimental Study].
    Zhao Y; Deng L; Cao Y; Ma B; Li Y; Xu J; Li H; Huang Y
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2024 Jan; 55(1):111-117. PubMed ID: 38322531
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ginsenoside Rd Inhibits the Metastasis of Colorectal Cancer via Epidermal Growth Factor Receptor Signaling Axis.
    Phi LTH; Sari IN; Wijaya YT; Kim KS; Park K; Cho AE; Kwon HY
    IUBMB Life; 2019 May; 71(5):601-610. PubMed ID: 30576064
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ginsenoside Rg3 sensitizes human non-small cell lung cancer cells to γ-radiation by targeting the nuclear factor-κB pathway.
    Wang L; Li X; Song YM; Wang B; Zhang FR; Yang R; Wang HQ; Zhang GJ
    Mol Med Rep; 2015 Jul; 12(1):609-14. PubMed ID: 25738799
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The anti-metastatic effect of ginsenoside Rb2 in colorectal cancer in an EGFR/SOX2-dependent manner.
    Phi LTH; Wijaya YT; Sari IN; Yang YG; Lee YK; Kwon HY
    Cancer Med; 2018 Nov; 7(11):5621-5631. PubMed ID: 30264477
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of nonselective cyclooxygenase inhibition with low-dose ibuprofen on tumor growth, angiogenesis, metastasis, and survival in a mouse model of colorectal cancer.
    Yao M; Zhou W; Sangha S; Albert A; Chang AJ; Liu TC; Wolfe MM
    Clin Cancer Res; 2005 Feb; 11(4):1618-28. PubMed ID: 15746067
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antitumor activity of ginsenoside Rg3 in melanoma through downregulation of the ERK and Akt pathways.
    Meng L; Ji R; Dong X; Xu X; Xin Y; Jiang X
    Int J Oncol; 2019 Jun; 54(6):2069-2079. PubMed ID: 31081060
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Weichang'an and 5-fluorouracil suppresses colorectal cancer in a mouse model.
    Tao L; Yang JK; Gu Y; Zhou X; Zhao AG; Zheng J; Zhu YJ
    World J Gastroenterol; 2015 Jan; 21(4):1125-39. PubMed ID: 25632185
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tubeimoside-I, an inhibitor of HSPD1, enhances cytotoxicity of oxaliplatin by activating ER stress and MAPK signaling pathways in colorectal cancer.
    Wu T; Yu Y; Tu X; Ye L; Wang J; Xie C; Kuang K; Yu Y; Zhuge W; Wang Z; Cui R; Zheng Y
    J Ethnopharmacol; 2025 Jan; 336():118754. PubMed ID: 39208999
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.